“…Six ovarian cancer cell lines (YDOV-139, YDOV-157, YDOV-161, YDOV-13, YDOV-105, and YDOV-151) and four HOSE cell lines (HOSE 198, 209, 211, and 213), which had been previously established [24], were maintained in a 1:1 mixture of Medium 199 and MCDB 105 (Sigma, St. Louis, MO, USA) supplemented with 10% FBS (Gemini Bio-Products, Calabasas, CA, USA). Immortalized HOSE8695 (IHOSE8695) cells had been established previously [38] and were maintained in DMEM supplemented with 10% FBS (HyClone, UT, USA) and 1% antibiotics (Cellgro, Manassas, VA, USA). All cell lines were incubated at 37 °C in a humidified incubator with 5% CO 2 .…”